These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 14729230)

  • 1. Statins potentiate caspase-3 activity in immortalized murine neurons.
    Föcking M; Besselmann M; Trapp T
    Neurosci Lett; 2004 Jan; 355(1-2):41-4. PubMed ID: 14729230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent suppression of proliferation of a10 vascular smooth muscle cells by combined treatment with lovastatin and 3-allylfarnesol, an inhibitor of protein farnesyltransferase.
    Mattingly RR; Gibbs RA; Menard RE; Reiners JJ
    J Pharmacol Exp Ther; 2002 Oct; 303(1):74-81. PubMed ID: 12235235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered apoptotic responses in neurons lacking RhoB GTPase.
    Barberan S; McNair K; Iqbal K; Smith NC; Prendergast GC; Stone TW; Cobb SR; Morris BJ
    Eur J Neurosci; 2011 Dec; 34(11):1737-46. PubMed ID: 22098422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of macrophage elastase (MMP-12) gene expression by statins.
    Arikan MC; Shapiro SD; Mariani TJ
    J Cell Physiol; 2005 Jul; 204(1):139-45. PubMed ID: 15605420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lovastatin inhibits the growth and survival pathway of phosphoinositide 3-kinase/protein kinase B in immortalized rat brain neuroblasts.
    Cerezo-Guisado MI; Garcia-Marin LJ; Lorenzo MJ; Bragado MJ
    J Neurochem; 2005 Sep; 94(5):1277-87. PubMed ID: 16111478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between RhoB and caspase-2: changes with lovastatin-induced apoptosis.
    Kong JY; Rabkin SW
    Biochem Cell Biol; 2005 Oct; 83(5):608-19. PubMed ID: 16234849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of NMDA on staurosporine-induced activation of caspase-3 and LDH release in mouse neocortical and hippocampal cells.
    Kajta M; Trotter A; Lasoń W; Beyer C
    Brain Res Dev Brain Res; 2005 Nov; 160(1):40-52. PubMed ID: 16153713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein synthesis is required for caspase activation and induction of apoptosis by bisphosphonate drugs.
    Coxon FP; Benford HL; Russell RG; Rogers MJ
    Mol Pharmacol; 1998 Oct; 54(4):631-8. PubMed ID: 9765505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of c-Jun N-terminal kinase is required for mevastatin-induced apoptosis of salivary adenoid cystic carcinoma cells.
    Zhang S; Wang XL; Gan YH; Li SL
    Anticancer Drugs; 2010 Aug; 21(7):678-86. PubMed ID: 20629200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hierarchical recruitment by AMPA but not staurosporine of pro-apoptotic mitochondrial signaling in cultured cortical neurons: evidence for caspase-dependent/independent cross-talk.
    Beart PM; Lim ML; Chen B; Diwakarla S; Mercer LD; Cheung NS; Nagley P
    J Neurochem; 2007 Dec; 103(6):2408-27. PubMed ID: 17887970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultraviolet light-induced apoptotic death is impaired by the HMG-CoA reductase inhibitor lovastatin.
    Bardeleben Rv; Kaina B; Fritz G
    Biochem Biophys Res Commun; 2003 Jul; 307(2):401-7. PubMed ID: 12859971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lovastatin and mevastatin reduce basal and cytokine-stimulated production of prostaglandins from rat microglial cells in vitro: evidence for a mechanism unrelated to the inhibition of hydroxy-methyl-glutaryl CoA reductase.
    Tringali G; Vairano M; Dello Russo C; Preziosi P; Navarra P
    Neurosci Lett; 2004 Jan; 354(2):107-10. PubMed ID: 14698450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMG-CoA reductase inhibitors induce apoptosis in pericytes.
    Boucher K; Siegel CS; Sharma P; Hauschka PV; Solomon KR
    Microvasc Res; 2006 Mar; 71(2):91-102. PubMed ID: 16427097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lovastatin-induced apoptosis in human melanoma cell lines.
    Shellman YG; Ribble D; Miller L; Gendall J; Vanbuskirk K; Kelly D; Norris DA; Dellavalle RP
    Melanoma Res; 2005 Apr; 15(2):83-9. PubMed ID: 15846140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptotic injury in cultured human hepatocytes induced by HMG-CoA reductase inhibitors.
    Kubota T; Fujisaki K; Itoh Y; Yano T; Sendo T; Oishi R
    Biochem Pharmacol; 2004 Jun; 67(12):2175-86. PubMed ID: 15163549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamin B, caspase-3 activity, and apoptosis induction by a combination of HMG-CoA reductase inhibitor and COX-2 inhibitors: a novel approach in developing effective chemopreventive regimens.
    Swamy MV; Cooma I; Reddy BS; Rao CV
    Int J Oncol; 2002 Apr; 20(4):753-9. PubMed ID: 11894121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H; Fager G
    Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMG-CoA reductase inhibitors activate caspase-1 in human monocytes depending on ATP release and P2X7 activation.
    Liao YH; Lin YC; Tsao ST; Lin YC; Yang AJ; Huang CT; Huang KC; Lin WW
    J Leukoc Biol; 2013 Feb; 93(2):289-99. PubMed ID: 23159926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mevastatin promotes neuronal survival against Aβ-induced neurotoxicity through AMPK activation.
    Kornelius E; Li HH; Peng CH; Hsiao HW; Yang YS; Huang CN; Lin CL
    Metab Brain Dis; 2017 Dec; 32(6):1999-2007. PubMed ID: 28840430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mevastatin, an inhibitor of HMG-CoA reductase, induces apoptosis, differentiation and Rap1 expression in HL-60 cells.
    Kanno T; Kobuchi H; Kajitani N; Utsumi T; Yano H; Horton AA; Yasuda T; Utsumi K
    Physiol Chem Phys Med NMR; 2002; 34(1):1-15. PubMed ID: 12403272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.